Enovix (NASDAQ:ENVX) Issues Q1 2026 Earnings Guidance

Enovix (NASDAQ:ENVX) updated its first quarter 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of -0.180–0.140 for the period, compared to the consensus estimate of -0.190. The company issued revenue guidance of $6.5 million-$7.5 million, compared to the consensus revenue estimate of $8.8 million.

Enovix Price Performance

Shares of Enovix stock traded down $0.37 during trading on Thursday, hitting $5.79. 7,555,152 shares of the company’s stock traded hands, compared to its average volume of 6,405,381. Enovix has a twelve month low of $5.27 and a twelve month high of $16.49. The company has a market cap of $1.25 billion, a PE ratio of -7.25 and a beta of 2.13. The firm’s fifty day moving average price is $7.19 and its 200 day moving average price is $8.96. The company has a debt-to-equity ratio of 1.74, a current ratio of 9.72 and a quick ratio of 9.47.

Analysts Set New Price Targets

ENVX has been the subject of a number of recent analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Enovix in a report on Monday, December 29th. Canaccord Genuity Group cut their target price on shares of Enovix from $22.00 to $21.00 and set a “buy” rating for the company in a research note on Thursday, November 6th. JPMorgan Chase & Co. dropped their price target on Enovix from $12.00 to $10.00 and set a “neutral” rating for the company in a report on Wednesday, November 12th. TD Cowen reduced their price objective on Enovix from $15.00 to $7.50 and set a “hold” rating on the stock in a research note on Thursday. Finally, Cantor Fitzgerald decreased their target price on Enovix from $30.00 to $25.00 and set an “overweight” rating on the stock in a report on Thursday, November 6th. Six equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $16.75.

Key Stories Impacting Enovix

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Q4 results beat estimates — revenue of ~$11.3M (≈+16% YoY) and an EPS loss narrower than expected (reported -$0.14 vs. consensus -$0.17), showing top‑line growth and better‑than‑feared unit economics. Article Title
• Positive Sentiment: Gross-margin improvement and operating progress — gross profit rose sharply year‑over‑year and operating loss narrowed, indicating improving manufacturing yields/costs as production ramps. Article Title
• Neutral Sentiment: Management emphasized a manufacturing ramp and strategic market expansion on the earnings call — positive long‑term if execution continues, but timing and capital intensity remain uncertain. Earnings Transcript
• Negative Sentiment: Near‑term revenue guidance was cut materially — Q1 revenue outlook $6.5M–$7.5M versus consensus ~ $8.8M, which pressured sentiment because it signals a slower ramp than investors hoped. Article Title
• Negative Sentiment: Analyst reaction: TD Cowen lowered its price target from $15 to $7.50 and set a “hold” — a visible downgrade that likely amplified selling pressure.
• Negative Sentiment: Balance‑sheet and liquidity concerns — cash fell to about $106M (down significantly YoY) while total liabilities rose materially, increasing investor focus on cash burn and financing needs. Insider selling was also reported. Article Title

Hedge Funds Weigh In On Enovix

Several large investors have recently bought and sold shares of ENVX. Electron Capital Partners LLC raised its position in shares of Enovix by 13.8% during the 3rd quarter. Electron Capital Partners LLC now owns 8,038,396 shares of the company’s stock valued at $80,143,000 after acquiring an additional 972,103 shares during the last quarter. Geode Capital Management LLC increased its holdings in Enovix by 6.1% in the fourth quarter. Geode Capital Management LLC now owns 4,413,492 shares of the company’s stock valued at $32,268,000 after purchasing an additional 253,906 shares during the last quarter. State Street Corp lifted its stake in Enovix by 2.0% in the fourth quarter. State Street Corp now owns 3,959,029 shares of the company’s stock valued at $28,941,000 after buying an additional 77,079 shares during the period. Royal Bank of Canada boosted its holdings in Enovix by 18.0% during the fourth quarter. Royal Bank of Canada now owns 2,525,268 shares of the company’s stock worth $18,461,000 after buying an additional 385,983 shares during the last quarter. Finally, Fred Alger Management LLC boosted its holdings in Enovix by 58.9% during the fourth quarter. Fred Alger Management LLC now owns 2,292,315 shares of the company’s stock worth $16,757,000 after buying an additional 849,329 shares during the last quarter. 50.92% of the stock is currently owned by institutional investors and hedge funds.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.